The company Nucleus Genomics announced the launch of Nucleus Embryo yesterday, which they bill as "the first genetic ...

While it’s now a top source of biopharmaceutical innovation, we believe China’s biotech sector is still in its early stages.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The atopic dermatitis market across the seven major markets is forecast to nearly triple in value over the next decade, ...

It trades at 13.3 times forward earnings—below the industry average of 14, as measured by the NYSE Arca Pharmaceutical Index, ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announces the appointments of Dr Cristina Csimma as an independent ...

Three biomedical research projects conducted NCSU Wilson College of Textiles researchers demonstrate advances in health care ...

With updated Phase I/Ib data in hand, Arcus will launch a Phase III trial as it aims to compete with Merck, whose drug ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...